JiangSu WuZhong Pharmaceutical Development Co., Ltd. (600200.SS) SHH

Currency In CNY

AD

Valuation

Market Cap6.64B
Enterprise Value7.02B
P/E Ratio-2.33
PEG Ratio-0
Price/Sales Ratio0.26
Price/Book Ratio0.12
Enterprise/Revenue2.15
Enterprise/EBITDA172.79

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.11
Operating Margin-0.09
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.05

Income Statement

Revenue1.6B
Revenue/Share1.12
Gross Profit769.05M
EBITDA179.4M
Net Income70.48M
Diluted EPS0.1

Balance Sheet

Total Cash49.19M
Total Cash/Share0.07
Total Debt1.53B
Total Debt/Equity0.89
Current Ratio1.5
Book Value Per Share2.58

Price History

52-Week Change-96.82
52-Week High9.74
52-Week Low0.29
Moving Average 50 Days0.87
Moving Average 200 Days1.98

Statistics

Average Volume31.5M
Shares Outstanding710.88M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.34
Last Split Factor3:2
Last Split DateSeptember 07, 2006
AD